Status:

COMPLETED

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Lead Sponsor:

Stockholm South General Hospital

Conditions:

Biliary Tract Neoplasms

Pancreatic Neoplasms

Eligibility:

All Genders

20+ years

Phase:

PHASE4

Brief Summary

Less than 20% of patients with malignant distal bile duct (BD) obstruction (often pancreatic cancer) are suitable for resection surgery.In the rest,palliation treatment comes into focus. Jaundice caus...

Detailed Description

Secondary outcome measures (compare above) are complications caused by the stent or stent insertion and technical ease to insert the stent. To discover a 12% difference between the 2 groups, regarding...

Eligibility Criteria

Inclusion

  • pt more than 20yrs.
  • BD stenosis at least 2cm distal of the hepatic hilum, with typical malignant exposure radiologically.
  • Clinically in accordance with tumour.s-bilirubin more than 50 micromol per litre.
  • Radical surgery probably not possible(temporary-1month-plastic stenting for further investigation and then exchange to SEMS if estimated non-operable, after Rx is allowed).
  • The patient must be fully informed by his doctor orally and in writing prior to the procedure, and give her/his informed consent. Ultrasound or CT examination must be performed prior to Rx.

Exclusion

  • Informed consent not obtained.
  • Significant multiple intrahepatic stenosis by multiple tumour growth, not suitable for ERCP stenting.
  • Radical Surgery will probably take place. Suspicion of non-malignant obstruction-further investigation must be performed.
  • Not possible by anatomical reasons to reach the papilla, i.e because of prior operations.
  • prior BD stent inserted (metal stent or plastic stent \>1month).
  • Previously included in this trial. Prothrombin index more than 1.5. (normal \<1.1).

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2013

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00980889

Start Date

May 1 2009

End Date

May 1 2013

Last Update

April 8 2014

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Department of Surgery, Upper GI Div. South Hospital,

Stockholm, SLL, Sweden, 118 83

2

Sahlgrenska Universitetssjukhuset

Gothenburg, Sweden, 41345

3

Länssjukhuset Ryhov

Jönköping, Sweden, 551 85

4

Länssjukhuset i Kalmar

Kalmar, Sweden, 391 85

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction | DecenTrialz